The global multimodal imaging systems market is expected to grow at a CAGR of 5.3% from 2018 to reach $1,574.8 million by 2024.
Multimodal imaging combines the innate advantages of the fused imaging technologies synergistically, forming more powerful imaging modality. It combines techniques such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) to accurately identify the diseased and the normal tissues.
For instance, a combination of PET or Single-Photon Emission Computed Tomography (SPECT) and CT imaging, overcomes the low resolution of the PET or SPECT image with the high resolution of CT image. In addition, this combination provides high sensitivity to the procedure, enabling accurate diagnosis. Due to these benefits, the leading players are consistently launching new systems in the market. In 2017, Siemens Healthineers, a part of Siemens AG (Germany) launched Biograph Vision PET/CT system with reduced crystal elements, offering a higher spatial resolution that improves lesion detectability in cancer diagnosis.
In addition to diagnosis, this technique is also used in small animal imaging for drug discovery and development procedures. The technique helps in understanding dynamic biological processes, gene expression, enzyme and protein activity, progression, treatment of diseases, biodistribution, pharmacodynamics or pharmacokinetics of drug molecule in model organisms. Such imaging data assist researchers in the study of the fundamental aspects of human-system function and dysfunction.
Key players like Bruker Corporation (U.S.), MR Solutions Ltd. (U.K.), and PerkinElmer, Inc. (U.S.) are providing pre-clinical multimodal imaging systems for research applications. In 2018, Bruker Corporation (U.S.) introduced new preclinical PET/CT Si78 scanner for whole-body preclinical imaging with homogeneous, high-resolution, and quantitative PET/CT imaging with a large field of view.
Also, in 2018, MR Solutions Ltd. (U.K.) launched pre-clinical CT scan models for sequential multimodal imaging with MRI and CT scanners.
Key Topics Covered:
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
2 Research Methodology
2.1.1. Secondary Research
2.1.2. Primary Research
3 Executive Summary
4 Market Insights
4.2. Market Dynamics
22.214.171.124. Increasing Elderly Population Coupled with Growing Prevalence of Chronic Diseases
126.96.36.199. Growing Number of Hospitals and Imaging Centres
188.8.131.52. Technological Advancements in the Development of Imaging Systems
184.108.40.206. Increasing Adoption of Preclinical Imaging in Drug Discovery
220.127.116.11. High Cost of instruments and Imaging Facility Establishment
18.104.22.168. Paucity of Skilled Healthcare Professionals
22.214.171.124. Complexities in the Development of integrated Imaging Systems
126.96.36.199. Significant Opportunities from Developing Economies
4.3. Market Share Analysis of Key Players
5 Multimodal Imaging Systems Market, by Product
5.2. Multimodal Imaging Equipment
6 Multimodal Imaging Systems Market, by Technology
7 Multimodal Imaging Systems, by Application
7.2. Clinical Applications
7.3. Research Applications
8 Multimodal Imaging Systems Market, by End User
8.3. Diagnostic Centers
8.4. Academic and Research institutes
9 Multimodal Imaging Systems Market, by Geography
9.2. North America
9.3.6. Rest of Europe
9.4.4. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Latin America
9.5.2. Middle East & Africa
10 Competitive Landscape
10.2. New Product Launches
10.3. Partnerships and Acquisitions
10.5. Collaborations and Upgradations
11 Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Siemens AG
11.2. GE Healthcare
11.3. Koninklijke Philips N.V.
11.4. Bruker Corporation
11.5. Canon Inc.
11.6. Mediso Ltd.
11.7. MILabs B.V.
11.8. MR Solutions Ltd.
11.9. Northridge Tri-Modality Imaging, Inc.
11.10. PerkinElmer, Inc.
11.11. Shanghai United Imaging Healthcare Co., Ltd.
Buy This Premium Report, Please Email Us at: firstname.lastname@example.org Or Contact +91-9975400624